Wang Yongzhi

Fractionated resection on low grade gliomas involving Broca's area and insights to brain plasticity.

Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.

Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study.

[Effects of tension relaxation by small needle knife on muscle tension and nerve endings after compression of gracilis muscle in rats].

Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China.

Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome.

VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.

MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.

Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma.

Significance of miR-196b in tumor-related epilepsy of patients with gliomas.

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group.

Understanding high grade glioma: molecular mechanism, therapy and comprehensive management.

Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.

ZIP4 is a novel molecular marker for glioma.

Identifying Ki-67 specific miRNA-mRNA interactions in malignant astrocytomas.

BCL2A1 is a potential biomarker for postoperative seizure control in patients with low-grade gliomas.

Comparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastoma.

Correlation of preoperative seizures with clinicopathological factors and prognosis in anaplastic gliomas: a report of 198 patients from China.

Characterization of resting-state fMRI-derived functional connectivity in patients with deficiency versus excess patterns of major depression.

An infrasellar craniopharyngioma involving the sphenoid sinus and clivus.

A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs.

Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion.

Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.

Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.

CGCG clinical practice guidelines for the management of adult diffuse gliomas.

The Incidence and Risk Factors of Postoperative Entrapped Temporal Horn in Trigone Meningiomas.

Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.

Post-craniotomy intracranial infection in patients with brain tumors: a retrospective analysis of 5723 consecutive patients.

Intracranial fibrous xanthoma mimicking a falcine meningioma.

Unusual presentation of an intracranial hemangiopericytoma as a cystic intraparenchymal mass lesion closely mimicking a glioma.

Clinical Features, Radiologic Findings, and Surgical Outcomes of 65 Intracranial Psammomatous Meningiomas.

Role of KCNB1 in the prognosis of gliomas and autophagy modulation.

miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.

Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.

Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas.

A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas.

Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.

ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.

Brain activity in patients with deficiency versus excess patterns of major depression: A task fMRI study.

ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme.

Clinical characteristics of and treatment protocol for trapped temporal horn following resection of lateral ventricular trigone meningioma: a single-center experience.

mA RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas.

Differentiation of glioblastoma from solitary brain metastases using radiomic machine-learning classifiers.

Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.

Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.

Depression comorbid with hyperalgesia: Different roles of neuroinflammation induced by chronic stress and hypercortisolism.

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.

A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide.

[Effect of the small needle knife through the Zusanli(ST 36) on behavior and hippocampal expression of NLRP3 and IL-1β in myalgia comorbid depressed rats].

Brain Functional Differences in Drug-Naive Major Depression with Anxiety Patients of Different Traditional Chinese Medicine Syndrome Patterns: A Resting-State fMRI Study.

The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.

Clinicopathological characteristics and survival of spinal cord astrocytomas.

Clinical practice guidelines for the management of adult diffuse gliomas.

Transcriptional Characteristics of -Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of -Wild Type WHO Grade IV Gliomas.

A comprehensive model including preoperative peripheral blood inflammatory markers for prediction of the prognosis of diffuse spinal cord astrocytoma following surgery.

Predictive value of MGMT promoter methylation on the survival of TMZ treated -mutant glioblastoma.

Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution.

METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.

Spinal Cord Diffuse Midline Gliomas With H3 K27m-Mutant: Clinicopathological Features and Prognosis.

YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated mA modification to activate NF-κB and promote the malignant progression of glioma.

Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages.

Alterations of monoamine neurotransmitters, HPA-axis hormones, and inflammation cytokines in reserpine-induced hyperalgesia and depression comorbidity rat model.

Automated Classification of Intramedullary Spinal Cord Tumors and Inflammatory Demyelinating Lesions Using Deep Learning.

Deep learning based on preoperative magnetic resonance (MR) images improves the predictive power of survival models in primary spinal cord astrocytomas.

Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging.

Molecular pathology and clinical implications of diffuse glioma.

Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.

Long-term outcomes of foramen magnum decompression with duraplasty for Chiari malformation type I in adults: a series of 297 patients.

Clinical management and prognosis of spinal myxopapillary ependymoma: a single-institution cohort of 72 patients.

Long-term outcome and prognostic factors of syringo-subarachnoid shunt for syringomyelia.

Lysine methylation promotes NFAT5 activation and determines temozolomide efficacy in glioblastoma.

Corrigendum to "METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma" [Canc. Lett. 511 (2021) 36-46].

Automated Determination of the H3 K27-Altered Status in Spinal Cord Diffuse Midline Glioma by Radiomics Based on T2-Weighted MR Images.

Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors.

Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management.

The predictive value of intraoperative bulbocavernosus reflex monitoring for postoperative voiding function in patients with conus medullaris and cauda equina tumors: a retrospective single center study.

Central nervous system dissemination in spinal cord astrocytomas: association with H3 K27M mutation.